In CF, your lungs produce extra-thick, sticky mucus. In laboratory studies, Pulmozyme made this mucus thinner and looser.
Cystic fibrosis patients over age 21 may benefit from twice-daily dosing to reduce the risk of lung infections requiring IV antibiotics.
Ask your doctor if twice daily is right for you. See the doctor discussion guide
Pulmozyme is a standard part of cystic fibrosis care. More than 80% of patients with cystic fibrosis are prescribed Pulmozyme each year. If you’re just getting started on Pulmozyme, learn about financial support options.
Learn how each treatment makes an impact
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Su navegador está configurado en español. ¿Preferirías el sitio en español?